A carregar...

The evolution of S100B inhibitors for the treatment of malignant melanoma

Malignant melanoma continues to be an extremely fatal cancer due to a lack of viable treatment options for patients. The calcium-binding protein S100B has long been used as a clinical biomarker, aiding in malignant melanoma staging and patient prognosis. However, the discovery of p53 as a S100B targ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hartman, Kira G, McKnight, Laura E, Liriano, Melissa A, Weber, David J
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575173/
https://ncbi.nlm.nih.gov/pubmed/23256816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.191
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!